Article title: Proton pump inhibitors may reduce the risk of high-grade dysplasia and/or esophageal adenocarcinoma in Barrett’s esophagus: a systematic review and meta-analysis
Authors: Yao H, Wang L, Li H, et al.
Journal: EXPERT REVIEW OF CLINICAL PHARMACOLOGY
Bibliometrics: Volume 15, Number 1, pages 79-88
DOI: https://doi.org/10.1080/17512433.2022.2008909
When this article was published online in issue there was an error which is now corrected as below.
On page 83, section 3.5.1.3 –
The sentence “According to the study quality (moderate-quality vs. high-quality), PPIs significantly reduced the risk of HGD and/or EAC in patients with BE among high-quality studies (RR=0.39; P<0.001), but not those moderate-quality studies (RR=0.37; P=0.012)”
is modified to
“Regardless of study quality (moderate-quality vs. high-quality), PPIs significantly reduced the risk of HGD and/or EAC in BE patients (RR=0.39; P<0.001 vs. RR=0.37; P=0.012)”, because the difference is statistically significant in both moderate-quality and high-quality subgroups analyses.